Who is sponsoring NCT05324605?

NCT05324605 is sponsored by Prof. Dr. med. Serge Marbacher.

What drugs are being tested in NCT05324605?

Interventions in NCT05324605: Questionnaire and use of 3 D tools.

What condition does NCT05324605 study?

NCT05324605 studies Aneurysm Cerebral.

Is NCT05324605 still recruiting?

NCT05324605 is currently completed. Last updated 17 October 2024.

Last reviewed 2024-10-17 · How we verify

NCT05324605: 3 D

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Personalized Treatment Planning in Intracranial Aneurysm Surgeries.

Completed Last updated 17 October 2024

What this trial tests

trial testing Questionnaire and use of 3 D tools in Aneurysm Cerebral in 30 participants. Completed in 31 December 2023.

Timeline

1 January 2021

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Prof. Dr. med. Serge Marbacher
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 January 2021
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Switzerland

Drugs / interventions tested

Questionnaire and use of 3 D tools

Conditions studied

Aneurysm Cerebral — all drugs for Aneurysm Cerebral →

Sponsor

Prof. Dr. med. Serge Marbacher

Who can join

18 and older, any sex, with Aneurysm Cerebral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients who will undergo a intracranial aneurysm (IA) surgery are educated concerning their disease and the surgical procedure.The objective of this study is to explore the advantages of conventional, virtual reality and 3D stereolithographic models for patient and resident education in the treatment of lAs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aneurysm Cerebral

Currently open trials in the same condition.

NCT07050381 — The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM · recruiting
NCT06033378 — Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05324605 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof. Dr. med. Serge Marbacher
Last refreshed: 17 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05324605.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing